Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety

PURPOSE: The aim of this study was to assess the efficacy and safety of paliperidone palmitate (PP) treatment compared with risperidone long-acting injectable (LAI) treatments for patients with schizophrenia. PATIENTS AND METHODS: Data mining was conducted in April 2022 across PubMed, Web of Science...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingjun, Qin, Bin, Mao, Yage, Zhang, Yang, Zhao, Ruisheng, Wang, Aiqin, Wang, Hailing, Zhao, Jianting, Wang, Changhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083027/
https://www.ncbi.nlm.nih.gov/pubmed/37041857
http://dx.doi.org/10.2147/NDT.S407259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083027/
https://www.ncbi.nlm.nih.gov/pubmed/37041857
http://dx.doi.org/10.2147/NDT.S407259

Ejemplares similares